<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1340" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1340/" /><meta name="ncbi_pagename" content="Charcot-Marie-Tooth Neuropathy Type 4C - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Charcot-Marie-Tooth Neuropathy Type 4C - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Charcot-Marie-Tooth Neuropathy Type 4C" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2015/10/15" /><meta name="citation_author" content="Hamid Azzedine" /><meta name="citation_author" content="Eric LeGuern" /><meta name="citation_author" content="Mustafa A Salih" /><meta name="citation_pmid" content="20301514" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1340/" /><meta name="citation_keywords" content="Charcot-Marie-Tooth Disease Type 4C" /><meta name="citation_keywords" content="CMT4C" /><meta name="citation_keywords" content="CMT4C" /><meta name="citation_keywords" content="Charcot-Marie-Tooth Disease Type 4C" /><meta name="citation_keywords" content="SH3 domain and tetratricopeptide repeat-containing protein 2" /><meta name="citation_keywords" content="SH3TC2" /><meta name="citation_keywords" content="Charcot-Marie-Tooth Neuropathy Type 4C" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Charcot-Marie-Tooth Neuropathy Type 4C" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Hamid Azzedine" /><meta name="DC.Contributor" content="Eric LeGuern" /><meta name="DC.Contributor" content="Mustafa A Salih" /><meta name="DC.Date" content="2015/10/15" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1340/" /><meta name="description" content="Charcot-Marie-Tooth neuropathy type 4C (CMT4C) is a demyelinating neuropathy characterized by early-onset severe spine deformities. The majority of affected children present with scoliosis or kyphoscoliosis between ages two and ten years, although earlier and later onset are observed. Slowly progressive neuropathy usually manifests in the first decade or adolescence, and occasionally earlier or later. Foot deformities (pes cavus, pes planus, or pes valgus) are common." /><meta name="og:title" content="Charcot-Marie-Tooth Neuropathy Type 4C" /><meta name="og:type" content="book" /><meta name="og:description" content="Charcot-Marie-Tooth neuropathy type 4C (CMT4C) is a demyelinating neuropathy characterized by early-onset severe spine deformities. The majority of affected children present with scoliosis or kyphoscoliosis between ages two and ten years, although earlier and later onset are observed. Slowly progressive neuropathy usually manifests in the first decade or adolescence, and occasionally earlier or later. Foot deformities (pes cavus, pes planus, or pes valgus) are common." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1340/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/cmt4c/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1340/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8A6C7CE041B6F10000000005EF0221.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1340_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1340_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cmt4/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cmt4h/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1340_"><span class="title" itemprop="name">Charcot-Marie-Tooth Neuropathy Type 4C</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Charcot-Marie-Tooth Disease Type 4C, CMT4C</div><p class="contrib-group"><span itemprop="author">Hamid Azzedine</span>, PhD, <span itemprop="author">Eric LeGuern</span>, MD, PhD, and <span itemprop="author">Mustafa A Salih</span>, MD, Dr Med Sci, FRCPCH, FAAN.</p><a data-jig="ncbitoggler" href="#__NBK1340_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1340_ai__"><div class="contrib half_rhythm"><span itemprop="author">Hamid Azzedine</span>, PhD<div class="affiliation small">Institute for Neuropathology<br />Uniklinik-RWTH<br />Aachen, Germany<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rf.oohay@dimah.enidezza" class="oemail">rf.oohay@dimah.enidezza</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Eric LeGuern</span>, MD, PhD<div class="affiliation small">Center for Molecular and Cellular Neurogenetics<br />La Piti&#x000e9;-Salp&#x000ea;tri&#x000e8;re Hospital<br />Paris, France</div></div><div class="contrib half_rhythm"><span itemprop="author">Mustafa A Salih</span>, MD, Dr Med Sci, FRCPCH, FAAN<div class="affiliation small">Division of Pediatric Neurology<br />College of Medicine<br />King Saud University<br />Riyadh, Saudi Arabia</div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">March 31, 2008</span>; Last Update: <span itemprop="dateModified">October 15, 2015</span>.</p><p><em>Estimated reading time: 21 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="cmt4c.Summary" itemprop="description"><h2 id="_cmt4c_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Charcot-Marie-Tooth neuropathy type 4C (CMT4C) is a demyelinating neuropathy characterized by early-onset severe spine deformities. The majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children present with scoliosis or kyphoscoliosis between ages two and ten years, although earlier and later onset are observed. Slowly progressive neuropathy usually manifests in the first decade or adolescence, and occasionally earlier or later. Foot deformities (<i>pes cavus</i>, <i>pes planus</i>, or <i>pes valgus</i>) are common.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Diagnosis is based on clinical findings, the results of motor nerve conduction velocity testing, and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>SH3TC2</i>, the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause CMT4C. Because the diagnosis of CMT4C is defined by the presence of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>SH3TC2</i> pathogenic variants, all individuals with CMT4C have pathogenic variants in this gene.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Treatment of spinal deformities includes physiotherapy to preserve flexibility, bracing, and/or surgery, even at a young age. Treatment of foot deformities includes special shoes with good ankle support and/or ankle/foot orthoses (AFOs) to correct foot drop and aid walking, and in some cases surgery; associated pain and cramps may require medication.</p><p><i>Prevention of secondary complications:</i> Daily heel cord stretching exercises and physical activity may help prevent contractures.</p><p><i>Surveillance:</i> Monitor for onset and/or progression of scoliosis and changes in hand function and foot strength.</p><p><i>Agents/circumstances to avoid:</i> Obesity; drugs and medications known to cause nerve damage (e.g., vincristine, isoniazid, taxol, cisplatin, nitrofurantoin).</p><p><i>Pregnancy management:</i> Symptoms of CMT can worsen during pregnancy; some studies suggest that women with CMT require more interventions during delivery (possibly secondary to an increased incidence of abnormal fetal presentation) and may be at increased risk for postpartum bleeding.</p><p><i>Other:</i> Career and employment may be influenced by hand and/or foot weakness.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>CMT4C is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk family members and prenatal testing for at-risk pregnancies are possible if both pathogenic variants have been identified in the family.</p></div></div><div id="cmt4c.Diagnosis"><h2 id="_cmt4c_Diagnosis_">Diagnosis</h2><div id="cmt4c.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Charcot-Marie-Tooth neuropathy type 4C (CMT4C) <b>should be suspected</b> in individuals with the following clinical manifestations, nerve conduction velocities, neuropathology, and family history:</p><p><b>Clinical manifestations</b></p><ul><li class="half_rhythm"><div>Early and severe scoliosis, the presenting sign in most individuals [<a class="bk_pop" href="#cmt4c.REF.kessali.1997.867">Kessali et al 1997</a>, <a class="bk_pop" href="#cmt4c.REF.gabre_lsfesten.1999.569">Gabre&#x000eb;ls-Festen et al 1999</a>, <a class="bk_pop" href="#cmt4c.REF.azzedine.2006.602">Azzedine et al 2006</a>]</div></li><li class="half_rhythm"><div>Neuropathy that usually develops in the first decade or adolescence, but occasionally manifests as delay in onset of independent ambulation in early childhood</div></li><li class="half_rhythm"><div>Slowly progressive neuropathy, with some individuals becoming wheelchair dependent because of involvement of the proximal lower limbs</div></li></ul><p><b>Motor nerve conduction velocities</b> (MNCV) that are in the range observed in demyelinating disease:</p><ul><li class="half_rhythm"><div>MNCV of the median nerve is typically 4-37 m/sec, with a mean of 22 m/sec.</div></li><li class="half_rhythm"><div>MNCV is not correlated with disease duration.</div></li><li class="half_rhythm"><div>In some cases, electroneuromyographic examination is incomplete or does not allow measurement of MNCVs because of the severity of the secondary axonal loss.</div></li></ul><p><b>Neuropathology.</b> Nerve biopsies show a combination of morphologic features unique among the demyelinating forms of CMT [<a class="bk_pop" href="#cmt4c.REF.kessali.1997.867">Kessali et al 1997</a>, <a class="bk_pop" href="#cmt4c.REF.gabre_lsfesten.1999.569">Gabre&#x000eb;ls-Festen et al 1999</a>, <a class="bk_pop" href="#cmt4c.REF.gooding.2005.e69">Gooding et al 2005</a>], including the following:</p><ul><li class="half_rhythm"><div>Loss of myelinated fibers</div></li><li class="half_rhythm"><div>Relatively few and small classic onion bulbs, as observed in CMT1A</div></li><li class="half_rhythm"><div>Basal membrane onion bulbs, consisting of concentric Schwann cell lamellae intermingled with single or double basal membranes or concentric basal membranes alone</div></li><li class="half_rhythm"><div>Schwann cells of unmyelinated axons, often with very thin processes and connecting links between axons</div></li></ul><p><b>Family history</b> consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance (includes <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases, i.e., a single occurrence in a family)</p></div><div id="cmt4c.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of CMT4C <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with early and severe scoliosis, slowly progressive neuropathy, slow nerve conduction velocities, and <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>SH3TC2</i> (previously known as <i>KIAA1985</i>) [<a class="bk_pop" href="#cmt4c.REF.senderek.2003.1106">Senderek et al 2003</a>] (see <a class="figpopup" href="/books/NBK1340/table/cmt4c.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figcmt4cTmoleculargenetictestingusedi" rid-ob="figobcmt4cTmoleculargenetictestingusedi">Table 1</a>).</p><p>Molecular testing approaches can include <b>serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>.</p><p><b>Serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> can be considered based on the order in which pathogenic variants most commonly occur in individuals with the above <a href="#cmt4c.Suggestive_Findings">suggestive findings</a>:</p><ul><li class="half_rhythm"><div>For <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases, exclusion of 17p11.2 <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> and pathogenic variants in <i>PMP22</i> (CMT1A) (see <a href="/books/n/gene/cmt/">CMT Overview</a>), <i>MPZ</i> (CMT1B) (see <a href="/books/n/gene/cmt/">CMT Overview</a>), and <i>GJB1</i>, which encodes connexin 32 (CMT1X) (see <a href="/books/n/gene/cmtx/">CMTX</a>)</div></li><li class="half_rhythm"><div>Sequence analysis of <i>SH3TC2</i> followed by <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found</div></li><li class="half_rhythm"><div>If <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> does not identify <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>SH3TC2</i> pathogenic variants, consideration of other demyelinating neuropathies. Of note, two (20%) of ten individuals with various neuropathies associated with pathogenic variants in <i>EGR2</i> had scoliosis [<a class="bk_pop" href="#cmt4c.REF.szigeti.2007.257">Szigeti et al 2007</a>] (see also <a href="#cmt4c.Differential_Diagnosis">Differential Diagnosis</a>).</div></li></ul><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>SH3TC2</i> and other genes of interest (see <a href="#cmt4c.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>, and mitochondrial sequencing may be considered if serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) fails to confirm a diagnosis in an individual with features of CMT4C. For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="cmt4c.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Charcot-Marie-Tooth Neuropathy Type 4C</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1340/table/cmt4c.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cmt4c.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cmt4c.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_cmt4c.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_cmt4c.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_cmt4c.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SH3TC2</i></td><td headers="hd_h_cmt4c.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_cmt4c.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_cmt4c.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_cmt4c.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="cmt4c.TF.1.1"><p class="no_margin">See <a href="/books/NBK1340/#cmt4c.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="cmt4c.TF.1.2"><p class="no_margin">See <a href="#cmt4c.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="cmt4c.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="cmt4c.TF.1.4"><p class="no_margin">Because this disorder is defined by the presence of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in the associated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, the variant detection rate is 100% for pathogenic variants detectable through <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</p></div></dd><dt>5. </dt><dd><div id="cmt4c.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="cmt4c.TF.1.6"><p class="no_margin">No deletions or duplications involving <i>SH3TC2</i> have been reported to cause Charcot-Marie-Tooth neuropathy type 4C.</p></div></dd></dl></div></div></div></div></div><div id="cmt4c.Clinical_Characteristics"><h2 id="_cmt4c_Clinical_Characteristics_">Clinical Characteristics</h2><div id="cmt4c.Clinical_Description"><h3>Clinical Description</h3><p>Charcot-Marie-Tooth neuropathy type 4C (CMT4C) is a demyelinating neuropathy characterized by early-onset severe scoliosis. Scoliosis as well as foot deformities were the presenting findings in most individuals with CMT4C.</p><p><b>Spine deformities</b> (scoliosis or kyphoscoliosis) were observed between ages two and ten years in most cases [<a class="bk_pop" href="#cmt4c.REF.kessali.1997.867">Kessali et al 1997</a>, <a class="bk_pop" href="#cmt4c.REF.gabre_lsfesten.1999.569">Gabre&#x000eb;ls-Festen et al 1999</a>], or more rarely, early in the second decade [<a class="bk_pop" href="#cmt4c.REF.senderek.2003.1106">Senderek et al 2003</a>]. However, the disease may start at birth or much later: onset at age 37 years was reported in one individual [<a class="bk_pop" href="#cmt4c.REF.colomer.2006.449">Colomer et al 2006</a>].</p><p>Cumulative data indicate that scoliosis occurs in 73% of persons with CMT4C (<a class="figpopup" href="/books/NBK1340/table/cmt4c.T.occurrence_of_manifestations_of/?report=objectonly" target="object" rid-figpopup="figcmt4cToccurrenceofmanifestationsof" rid-ob="figobcmt4cToccurrenceofmanifestationsof">Table 2</a>). In some cases the spine deformities are moderate; in others they are disabling. The curvature progressed three to five degrees annually and required surgery in 7% to 39% of reported cases (<a class="figpopup" href="/books/NBK1340/table/cmt4c.T.occurrence_of_manifestations_of/?report=objectonly" target="object" rid-figpopup="figcmt4cToccurrenceofmanifestationsof" rid-ob="figobcmt4cToccurrenceofmanifestationsof">Table 2</a>) [<a class="bk_pop" href="#cmt4c.REF.kessali.1997.867">Kessali et al 1997</a>, <a class="bk_pop" href="#cmt4c.REF.gabre_lsfesten.1999.569">Gabre&#x000eb;ls-Festen et al 1999</a>].</p><p><b>Foot deformities</b> (<i>pes cavus</i>, <i>pes planus</i>, or <i>pes valgus</i>) were reported in 72% to 100% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#cmt4c.REF.senderek.2003.1106">Senderek et al 2003</a>, <a class="bk_pop" href="#cmt4c.REF.azzedine.2006.602">Azzedine et al 2006</a>, <a class="bk_pop" href="#cmt4c.REF.colomer.2006.449">Colomer et al 2006</a>]. Foot deformities were first observed between ages two and ten years, were moderately or severely disabling, and required surgery in 6% (1/18) to 11% (3/28) of cases (<a class="figpopup" href="/books/NBK1340/table/cmt4c.T.occurrence_of_manifestations_of/?report=objectonly" target="object" rid-figpopup="figcmt4cToccurrenceofmanifestationsof" rid-ob="figobcmt4cToccurrenceofmanifestationsof">Table 2</a>).</p><div id="cmt4c.T.occurrence_of_manifestations_of" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Occurrence of Manifestations of CMT4C by Study</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1340/table/cmt4c.T.occurrence_of_manifestations_of/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cmt4c.T.occurrence_of_manifestations_of_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_1" rowspan="2" colspan="2" scope="colgroup" headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_1" style="text-align:left;vertical-align:middle;">Study Finding</th><th id="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2" colspan="8" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Study (Total Patients)</th><th id="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></th></tr><tr><th headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2" id="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#cmt4c.REF.azzedine.2006.602">Azzedine et al [2006]</a><br />(28)</th><th headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2" id="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#cmt4c.REF.colomer.2006.449">Colomer et al [2006]</a><br />(14)</th><th headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2" id="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#cmt4c.REF.senderek.2003.1106">Senderek et al [2003]</a><br />(18)</th><th headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2" id="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#cmt4c.REF.houlden.2009.264">Houlden et al [2009]</a><br />(6)</th><th headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2" id="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#cmt4c.REF.baets.2011.2664">Baets et al [2011]</a><br />(9)</th><th headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2" id="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#cmt4c.REF.la__uthov_.2011.334">La&#x00161;&#x00161;uthov&#x000e1; et al [2011]</a><br />(16)</th><th headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2" id="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_7" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#cmt4c.REF.yger.2012.112">Yger et al [2012]</a><br />(14)</th><th headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2" id="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_8" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#cmt4c.REF.fischer.2012.515">Fischer et al [2012]</a><br />(6)</th><th headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_3" id="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_9" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cumulative Data</th></tr></thead><tbody><tr><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Age at onset</b></td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>1<sup>st</sup> symptoms</b></td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2-10</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4-39</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Infancy-12</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1-16</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1-12</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1-12</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ND</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_3 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1-16</td></tr><tr><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Neuropathy</b></td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2-10</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Infancy-12</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1-16</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2-50</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2-50</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2-25</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_3 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1-50</td></tr><tr><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Age at (last) exam (yrs)</b></td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5-45</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8-45</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11-56</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8-42</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ND</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ND</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8-59</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_3 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5-59</td></tr><tr><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_1" rowspan="7" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Foot deformity</b></td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b><i>Pes cavus</i></b></td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">20/28</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_2" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">14/14&#x000a0;<sup>1</sup></td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8/18</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Yes</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ND</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">13/15</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12/14</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ND</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_3 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b><i>Pes planus</i></b></td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7/28</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">4/18</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Yes</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ND</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">no</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">no</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ND</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_3 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b><i>Pes valgus</i></b></td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/28</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">ND</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ND</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ND</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">no</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3/14</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ND</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_3 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Other</b></td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hammer toes 8/18</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Small feet</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ND</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hammer toes</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">no</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ND</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_3 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Total</b></td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">28/28</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">14/14</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">13/18&#x000a0;<sup>2</sup></td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6/6&#x000a0;<sup>1</sup></td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7/9</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">14/15</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">14/14</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ND</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_3 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">96/104 (92%)</td></tr><tr><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Age at onset (yrs)</b></td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2-10</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No data</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2-12</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ND</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ND</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ND</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1,12&#x000a0;<sup>3</sup></td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ND</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_3 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1-12</td></tr><tr><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Surgery</b></td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3/28</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/13</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ND</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9/14</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4/14</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ND</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_3 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">17/69 (24%)</td></tr><tr><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Spine deformity</b></td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Total</b></td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">27/28</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5/14&#x000a0;<sup>4</sup></td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11/18&#x000a0;<sup>4</sup></td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6/6</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6/9</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10/12</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12/12</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5/6</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_3 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">82/105 (78%)</td></tr><tr><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Age at onset (yrs)</b></td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2-10</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4-12&#x000a0;<sup>5</sup></td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ND</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2, 6, 7, 12&#x000a0;<sup>6</sup></td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ND</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7-15</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ND</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_3 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2-15</td></tr><tr><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Surgery</b></td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7&#x000a0;<sup>7</sup> + 6&#x000a0;<sup>8</sup> = 13/27</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/14</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/11</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3/6</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3/6</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ND</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/12</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_2 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ND</td><td headers="hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_1_3 hd_h_cmt4c.T.occurrence_of_manifestations_of_1_1_2_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">22/76 (29%)</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">ND = not done or not documented</p></div></dd><dt>1. </dt><dd><div id="cmt4c.TF.2.1"><p class="no_margin">Authors did not specify type of deformities.</p></div></dd><dt>2. </dt><dd><div id="cmt4c.TF.2.2"><p class="no_margin">Authors did not specify the foot deformity in the one patient who had surgery.</p></div></dd><dt>3. </dt><dd><div id="cmt4c.TF.2.3"><p class="no_margin">Unknown for 12 of 14 patients</p></div></dd><dt>4. </dt><dd><div id="cmt4c.TF.2.4"><p class="no_margin">Authors did not indicate whether they evaluated for kyphoscoliosis and/or lordosis.</p></div></dd><dt>5. </dt><dd><div id="cmt4c.TF.2.5"><p class="no_margin">Onset of scoliosis in infancy; age not reported</p></div></dd><dt></dt><dd><div><p class="no_margin">6.Age documented in 4 patients only</p></div></dd><dt>7. </dt><dd><div id="cmt4c.TF.2.6"><p class="no_margin"><a class="bk_pop" href="#cmt4c.REF.kessali.1997.867">Kessali et al [1997]</a></p></div></dd><dt>8. </dt><dd><div id="cmt4c.TF.2.7"><p class="no_margin"><a class="bk_pop" href="#cmt4c.REF.gabre_lsfesten.1999.569">Gabre&#x000eb;ls-Festen et al [1999]</a></p></div></dd></dl></div></div></div><p><b>Other.</b> No data are available on cramps and pain in individuals with CMT4C. In general, cramps and pain are common in all forms of CMT, occurring in 56 to 96% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, according to different studies [<a class="bk_pop" href="#cmt4c.REF.carter.1998.1560">Carter et al 1998</a>, <a class="bk_pop" href="#cmt4c.REF.abresch.2002.39">Abresch et al 2002</a>, <a class="bk_pop" href="#cmt4c.REF.tiffreau.2006.756">Tiffreau et al 2006</a>, <a class="bk_pop" href="#cmt4c.REF.padua.2008.193">Padua et al 2008</a>]. Cramps are usually present from the onset, whereas pain may develop as the disease progresses.</p><p>Hypoacousis (slightly diminished auditory sensitivity) was reported in 15/103 persons with CMT4C and deafness (significant reduction of auditory sensitivity) in 12/103 persons. The cumulative data from the literature showed that hypoacousis and deafness were each present in approximately 11.5% and 14.5% of individuals, respectively (<a class="figpopup" href="/books/NBK1340/table/cmt4c.T.additional_clinical_findings_in/?report=objectonly" target="object" rid-figpopup="figcmt4cTadditionalclinicalfindingsin" rid-ob="figobcmt4cTadditionalclinicalfindingsin">Table 3</a>). For more detailed discussion of hearing loss in general, see <a href="/books/n/gene/deafness-overview/">Deafness and Hereditary Hearing Loss Overview</a>.</p><p>Nystagmus was reported in 2/18 persons with CMT4C [<a class="bk_pop" href="#cmt4c.REF.senderek.2003.1106">Senderek et al 2003</a>].</p><p>Pupillary light reflexes, facial paresis, hypoventilation/respiratory insufficiency, lingual fasciculation, head tremor, sensory ataxia, and diabetes mellitus were also reported (<a class="figpopup" href="/books/NBK1340/table/cmt4c.T.additional_clinical_findings_in/?report=objectonly" target="object" rid-figpopup="figcmt4cTadditionalclinicalfindingsin" rid-ob="figobcmt4cTadditionalclinicalfindingsin">Table 3</a>). The cumulative data from the literature showed that respiratory problems occurred in approximately 18% and cranial nerve involvement in 45% of individuals with CMT4C (<a class="figpopup" href="/books/NBK1340/table/cmt4c.T.additional_clinical_findings_in/?report=objectonly" target="object" rid-figpopup="figcmt4cTadditionalclinicalfindingsin" rid-ob="figobcmt4cTadditionalclinicalfindingsin">Table 3</a>).</p><div id="cmt4c.T.additional_clinical_findings_in" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Additional Clinical Findings in CMT4C by Study</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1340/table/cmt4c.T.additional_clinical_findings_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cmt4c.T.additional_clinical_findings_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Clinical Finding</th><th id="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2" colspan="8" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Study (Total Patients)</th></tr><tr><th headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2" id="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#cmt4c.REF.azzedine.2006.602">Azzedine et al [2006]</a><br />(28)</th><th headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2" id="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#cmt4c.REF.colomer.2006.449">Colomer et al [2006]</a><br />(14)</th><th headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2" id="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#cmt4c.REF.senderek.2003.1106">Senderek et al [2003]</a><br />(18)</th><th headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2" id="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#cmt4c.REF.houlden.2009.264">Houlden et al [2009]</a><br />(6)</th><th headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2" id="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#cmt4c.REF.baets.2011.2664">Baets et al [2011]</a><br />(9)</th><th headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2" id="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#cmt4c.REF.la__uthov_.2011.334">La&#x00161;&#x00161;uthov&#x000e1; et al [2011]</a><br />(16)</th><th headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2" id="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_7" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#cmt4c.REF.yger.2012.112">Yger et al [2012]</a><br />(14)</th><th headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2" id="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_8" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cumulative Data</th></tr></thead><tbody><tr><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypoacusis</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5/28</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0/14</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2/18</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0/6</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0/9</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0/15</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8/13</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15/103</td></tr><tr><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deafness</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0/28</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5/14</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/18</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2/6</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/9</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3/15</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0/13</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12/103</td></tr><tr><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Nystagmus</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0/28</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0/14</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2/18</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0/6</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2/9</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0/15</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0/13</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4/103</td></tr><tr><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pupillary light reflexes</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0/28</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3/14</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0/18</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/6</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0/9</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0/15</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">14/13</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4/20</td></tr><tr><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Other pupillary disturbances</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Asymmetric size 1/6</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/6</td></tr><tr><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Lingual fasciculation</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3/14</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3/14</td></tr><tr><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Tongue atrophy and/or weakness</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/6</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2/13</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3/19</td></tr><tr><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Facial paresis</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/28</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/6</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/9</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4/13</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7/56</td></tr><tr><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Facial weakness</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/6</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/6</td></tr><tr><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Head tremor</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2/14</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2/14</td></tr><tr><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Vocal cord involvement</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/13</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/13</td></tr><tr><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Total patients w/cranial nerve involvement</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5/28</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9/14</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5/14&#x000a0;<sup>1</sup></td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4/6</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10/13</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">33/73</td></tr><tr><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Respiratory insufficiency or hypoventilation</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7/28&#x000a0;<sup>2</sup></td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2/18</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/9</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10/55</td></tr><tr><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sensory ataxia</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/28</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2/14</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;3/42&#x000a0;<sup>3</sup></td></tr><tr><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Diabetes mellitus</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/18</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/18</td></tr><tr><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Romberg sign</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2/14</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cmt4c.T.additional_clinical_findings_in_1_1_1_2 hd_h_cmt4c.T.additional_clinical_findings_in_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2/14</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="cmt4c.TF.3.1"><p class="no_margin">14 of 18 patients were examined for cranial nerve involvement.</p></div></dd><dt>2. </dt><dd><div id="cmt4c.TF.3.2"><p class="no_margin"><a class="bk_pop" href="#cmt4c.REF.kessali.1997.867">Kessali et al [1997]</a> reported that 7/11 persons required spine surgery because the severity of their deformities caused difficulty in sitting and pulmonary restriction.</p></div></dd><dt>3. </dt><dd><div id="cmt4c.TF.3.3"><p class="no_margin"><a class="bk_pop" href="#cmt4c.REF.gabre_lsfesten.1999.569">Gabre&#x000eb;ls-Festen et al [1999]</a> reported mild sensory ataxia in some individuals, without indicating the number of cases.</p></div></dd></dl></div></div></div><p><b>Pregnancy.</b> See Management, <a href="#cmt4c.Pregnancy_Management">Pregnancy Management</a>.</p></div><div id="cmt4c.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Significant <a class="def" href="/books/n/gene/glossary/def-item/intrafamilial-variability/">intrafamilial variability</a> in the disease course makes it difficult to identify <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> [<a class="bk_pop" href="#cmt4c.REF.kessali.1997.867">Kessali et al 1997</a>, <a class="bk_pop" href="#cmt4c.REF.gabre_lsfesten.1999.569">Gabre&#x000eb;ls-Festen et al 1999</a>, <a class="bk_pop" href="#cmt4c.REF.senderek.2003.1106">Senderek et al 2003</a>, <a class="bk_pop" href="#cmt4c.REF.azzedine.a">Azzedine et al 2005a</a>, <a class="bk_pop" href="#cmt4c.REF.azzedine.b">Azzedine et al 2005b</a>, <a class="bk_pop" href="#cmt4c.REF.azzedine.2006.602">Azzedine et al 2006</a>].</p><ul><li class="half_rhythm"><div>In 28 individuals with CMT4C, <a class="bk_pop" href="#cmt4c.REF.azzedine.2006.602">Azzedine et al [2006]</a> found no correlation between the nature and the position of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, disease duration, and the stage of disability. They also reported <a class="def" href="/books/n/gene/glossary/def-item/intrafamilial-variability/">intrafamilial variability</a> in age at onset, disease duration, and stage of disability.</div></li><li class="half_rhythm"><div><a class="bk_pop" href="#cmt4c.REF.colomer.2006.449">Colomer et al [2006]</a> reported clinical variability in 14 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li></ul></div><div id="cmt4c.Prevalence"><h3>Prevalence</h3><p>CMT4C (caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>SH3TC2</i>) is a relatively frequent cause of the <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> demyelinating neuropathy CMT4. On the basis of the cumulative data, the prevalence of CMT4C among those with CMT4 is approximately 18% (53/299) [<a class="bk_pop" href="#cmt4c.REF.senderek.2003.1106">Senderek et al 2003</a>, <a class="bk_pop" href="#cmt4c.REF.azzedine.2006.602">Azzedine et al 2006</a>, <a class="bk_pop" href="#cmt4c.REF.houlden.2009.264">Houlden et al 2009</a>, <a class="bk_pop" href="#cmt4c.REF.fischer.2012.515">Fischer et al 2012</a>, <a class="bk_pop" href="#cmt4c.REF.iguchi.2013.283">Iguchi et al 2013</a>]. (See <a href="/books/n/gene/cmt/">CMT Overview</a>.)</p><p>Pathogenic variants in <i>SH3TC2</i> have been found in individuals of diverse geographic origins (Algeria, Morocco, France, Belgium, England, the Netherlands, Germany, Austria, Italy, Bosnia, Czech, Greece, Turkey, Iran, Japan, and Canada) and diverse ethnic origins (gypsies from Spain and Turkey) [<a class="bk_pop" href="#cmt4c.REF.leguern.1996.1685">LeGuern et al 1996</a>, <a class="bk_pop" href="#cmt4c.REF.gabre_lsfesten.1999.569">Gabre&#x000eb;ls-Festen et al 1999</a>, <a class="bk_pop" href="#cmt4c.REF.guilbot.1999.453">Guilbot et al 1999</a>, <a class="bk_pop" href="#cmt4c.REF.senderek.2003.1106">Senderek et al 2003</a>, <a class="bk_pop" href="#cmt4c.REF.azzedine.a">Azzedine et al 2005a</a>, <a class="bk_pop" href="#cmt4c.REF.azzedine.b">Azzedine et al 2005b</a>, <a class="bk_pop" href="#cmt4c.REF.azzedine.2006.602">Azzedine et al 2006</a>, <a class="bk_pop" href="#cmt4c.REF.colomer.2006.449">Colomer et al 2006</a>, <a class="bk_pop" href="#cmt4c.REF.houlden.2009.264">Houlden et al 2009</a>, <a class="bk_pop" href="#cmt4c.REF.baets.2011.2664">Baets et al 2011</a>, <a class="bk_pop" href="#cmt4c.REF.fischer.2012.515">Fischer et al 2012</a>].</p><ul><li class="half_rhythm"><div>The <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> p.Arg954Ter is recurrent in several populations, including people who originated from the Mediterranean basin, Europe, and America [<a class="bk_pop" href="#cmt4c.REF.azzedine.a">Azzedine et al 2005a</a>, <a class="bk_pop" href="#cmt4c.REF.azzedine.b">Azzedine et al 2005b</a>]. This <a class="def" href="/books/n/gene/glossary/def-item/founder-effect/">founder effect</a> leads to a bias in the occurrence of the disease in those populations [<a class="bk_pop" href="#cmt4c.REF.azzedine.a">Azzedine et al 2005a</a>, <a class="bk_pop" href="#cmt4c.REF.azzedine.b">Azzedine et al 2005b</a>, <a class="bk_pop" href="#cmt4c.REF.gosselin.2008.483">Gosselin et al 2008</a>].</div></li><li class="half_rhythm"><div>Five (20%) of 25 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals of Turkish origin had <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>SH3TC2</i> pathogenic variants [<a class="bk_pop" href="#cmt4c.REF.parman.2004.2540">Parman et al 2004</a>, <a class="bk_pop" href="#cmt4c.REF.fischer.2012.515">Fischer et al 2012</a>].</div></li></ul></div></div><div id="cmt4c.Genetically_Related_Allelic_Disord"><h2 id="_cmt4c_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>SH3TC2</i>.</p></div><div id="cmt4c.Differential_Diagnosis"><h2 id="_cmt4c_Differential_Diagnosis_">Differential Diagnosis</h2><p>See <a href="/books/n/gene/cmt/">CMT Overview</a> for discussion of approaches to diagnosis of other <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorders with peripheral neuropathy. Guidelines for genetic testing of individuals suspected of having a neuromuscular condition, such as CMT, have been published by <a class="bk_pop" href="#cmt4c.REF.burgunder.2011.207">Burgunder et al [2011]</a> and <a class="bk_pop" href="#cmt4c.REF.murphy.2012.706">Murphy et al [2012]</a>.</p><p><a class="bk_pop" href="#cmt4c.REF.baets.2011.2664">Baets et al [2011]</a> reviewed the genetic spectrum of hereditary neuropathies presenting in the first year of life. Besides CMT4C, the most common disorders are the CMT4 subtypes CMT4B2 (<i>SBF2</i>), CMT4F (<i>PRX</i>), and CMT4H (<i>FGD4</i>). However, these subtypes occur at a low frequency compared to CMT as a whole.</p><p><b>CMT4A/2H</b> is an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> axonal, demyelinating or mixed (RI-CMTA) sensory and motor peripheral neuropathy due most often to <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>GDAP1</i> [<a class="bk_pop" href="#cmt4c.REF.nelis.2002.1865">Nelis et al 2002</a>, <a class="bk_pop" href="#cmt4c.REF.birouk.2003.598">Birouk et al 2003</a>, <a class="bk_pop" href="#cmt4c.REF.bouhouche.2007.1062">Bouhouche et al 2007</a>]. In a few studies, single <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants in <i>GDAP1</i> were found to be inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner (CMT2K) [<a class="bk_pop" href="#cmt4c.REF.claramunt.2005.358">Claramunt et al 2005</a>]. CMT4A/2H is one of the most frequent autosomal recessive forms of CMT [Author, personal observation]. See <a href="/books/n/gene/cmt-4a/">CMT4A</a>.</p><p><b>CMT1E.</b> Autosomal recessive inheritance of severe neuropathy has also been reported with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>PMP22</i>, in which <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants typically cause the <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> CMT1 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p><a href="/books/n/gene/cmtx/"><b>CMT1X</b></a>, caused by <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> pathogenic variants in <i>GJB1</i> (<i>Cx32</i>), is characterized by a moderate to severe motor and sensory neuropathy in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males and usually mild to no symptoms in <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females. Sensorineural deafness and central nervous system symptoms also occur in some families. Unlike CMT4C, CMT1X is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner.</p><p><a href="/books/n/gene/accpn/"><b>Hereditary motor and sensory neuropathy with agenesis of the corpus callosum</b></a><b>,</b> an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> severe sensorimotor neuropathy with intellectual disability and agenesis of the corpus callosum has been reported in individuals from Quebec. It is caused by pathogenic variants in <i>SLC12A6</i> (former names: <i>ACCPN</i>, <i>KCC3</i>), the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding the K-Cl cotransporter [<a class="bk_pop" href="#cmt4c.REF.howard.2002.384">Howard et al 2002</a>].</p><p><b>Other unclassified <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> neuropathies</b></p><ul><li class="half_rhythm"><div><b><i>SURF1</i>.</b> Three individuals from <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> families with childhood-onset demyelinating motor/sensory neuropathy associated with nystagmus, lactic acidosis, hyperintense lesions in the putamen on T<sub>1</sub>-weighted MRI, and later development of cerebellar ataxia had deficiency of COX activity in muscle fibers associated with <i>SURF1</i> <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> or <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> pathogenic variants [<a class="bk_pop" href="#cmt4c.REF.echanizlaguna.2013.1523">Echaniz-Laguna et al 2013</a>]. Mutation of <i>SURF1</i> has also been associated with <a href="/books/n/gene/narp/">Leigh syndrome</a>.</div></li><li class="half_rhythm"><div><b><i>TRIM2</i></b>. Compound <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants have been reported in a female with childhood-onset axonal and demyelinating neuropathy with low weight and small muscle mass [<a class="bk_pop" href="#cmt4c.REF.ylikallio.2013.2975">Ylikallio et al 2013</a>]. Nerve biopsy showed enlarged myelinated fibers with increased density of neurofilaments. <i>TRIM2</i> is an E3 ubiquitin ligase.</div></li><li class="half_rhythm"><div><b><i>HINT1</i>.</b> Loss-of-function pathogenic variants cause a motor (greater than sensory) axonal neuropathy with neuromyotonia (spontaneous high-frequency motor unit potentials on EMG) [<a class="bk_pop" href="#cmt4c.REF.zimo_.2012.1080">Zimo&#x00144; et al 2012</a>]. <a class="bk_pop" href="#cmt4c.REF.hahn.1991.230">Hahn et al [1991]</a> described the clinical details of this disease including muscle cramping, twitching, and distal weakness.</div></li></ul></div><div id="cmt4c.Management"><h2 id="_cmt4c_Management_">Management</h2><div id="cmt4c.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Charcot-Marie-Tooth neuropathy type 4C (CMT4C), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Examination by a child neurologist to evaluate for weakness and atrophy, gait stability, sensory loss, and other associated signs. It is important to distinguish between neuropathic pain and mechanical pain.</div></li><li class="half_rhythm"><div>Examination by a pediatric orthopedist to assess the amount and progression of spinal curvature and to determine the extent of foot deformities</div></li><li class="half_rhythm"><div>Examination by an otolaryngologist and/or ophthalmologist if problems with hearing or vision are present</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="cmt4c.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Treatment is symptomatic. Affected individuals are often managed by a multidisciplinary team that includes neurologists, physiatrists, orthopedic surgeons, and physical and occupational therapists. See <a class="bk_pop" href="#cmt4c.REF.grandis.2005.23">Grandis &#x00026; Shy [2005]</a> for a discussion of general treatment for CMT.</p><p><b>Spinal deformities</b></p><ul><li class="half_rhythm"><div>Physiotherapy helps to preserve flexibility.</div></li><li class="half_rhythm"><div>If the curvature can be reduced with bracing, either a plaster or a thermo-molded plastic corset can be used.</div></li><li class="half_rhythm"><div>If bracing and physiotherapy together are not sufficient to correct the scoliosis, surgery can be performed at an early age, even before the end of linear growth (<a class="figpopup" href="/books/NBK1340/table/cmt4c.T.occurrence_of_manifestations_of/?report=objectonly" target="object" rid-figpopup="figcmt4cToccurrenceofmanifestationsof" rid-ob="figobcmt4cToccurrenceofmanifestationsof">Table 2</a>) [<a class="bk_pop" href="#cmt4c.REF.kessali.1997.867">Kessali et al 1997</a>, <a class="bk_pop" href="#cmt4c.REF.gabre_lsfesten.1999.569">Gabre&#x000eb;ls-Festen et al 1999</a>]. Surgical intervention requires consensus among the family, child (if possible), and attending physicians.</div></li></ul><p><b>Foot deformities</b></p><ul><li class="half_rhythm"><div>Special shoes with good ankle support and/or ankle/foot orthoses (AFOs) to correct foot drop and aid walking</div></li><li class="half_rhythm"><div>Physiotherapy to preserve flexibility</div></li><li class="half_rhythm"><div>In approximately 9% of individuals, surgery to correct severe <i>pes cavus</i> deformity (<a class="figpopup" href="/books/NBK1340/table/cmt4c.T.occurrence_of_manifestations_of/?report=objectonly" target="object" rid-figpopup="figcmt4cToccurrenceofmanifestationsof" rid-ob="figobcmt4cToccurrenceofmanifestationsof">Table 2</a>) [<a class="bk_pop" href="#cmt4c.REF.kessali.1997.867">Kessali et al 1997</a>, <a class="bk_pop" href="#cmt4c.REF.guyton.2000.317">Guyton &#x00026; Mann 2000</a>, <a class="bk_pop" href="#cmt4c.REF.colomer.2006.449">Colomer et al 2006</a>]</div></li></ul><p><b>Pain and cramps</b></p><ul><li class="half_rhythm"><div>Neuropathic pain can be treated with antiepileptic drugs (AEDs) (e.g., pregabalin, gabapentin).</div></li><li class="half_rhythm"><div>Mechanical pain can generally be managed with a combination of physiotherapy and orthopedic treatment.</div></li><li class="half_rhythm"><div>Cramps can be controlled with quinine. However, quinine is known to induce tinnitus and reversible high-tone hearing loss.</div></li></ul><p><b>Other</b></p><ul><li class="half_rhythm"><div>Some individuals require forearm crutches or canes for gait stability; some need wheelchairs.</div></li><li class="half_rhythm"><div>Exercise to help the individual remain physically active according to his/her abilities is encouraged.</div></li></ul></div><div id="cmt4c.Prevention_of_Secondary_Complicati"><h3>Prevention of Secondary Complications</h3><p>Daily heel cord stretching exercises help prevent Achilles' tendon shortening.</p><p>Physical activity (e.g., swimming, bicycling, stretching) adapted to the abilities of each individual by a physiotherapist is useful to prevent contractures.</p><p>Individuals with diabetes mellitus need excellent foot care to avoid foot ulceration and necrosis.</p></div><div id="cmt4c.Surveillance"><h3>Surveillance</h3><p>Scoliosis needs to be closely followed. Monitoring four times a year is recommended.</p><p>Hand function and foot strength should be evaluated by an orthopedist every six months starting from the date of diagnosis.</p></div><div id="cmt4c.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Obesity is to be avoided because it makes walking more difficult.</p><p>Medications which are toxic or potentially toxic to persons with CMT comprise a range of risks ranging from definite high risk to negligible risk. See the Charcot-Marie-Tooth Association <a href="https://www.cmtausa.org/living-with-cmt/managing-cmt/medications/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">website</a> (pdf) for an up-to-date list.</p></div><div id="cmt4c.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate apparently asymptomatic older and younger sibs of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual in order to identify as early as possible those who would benefit from initiation of preventive measures. Evaluations can include:</p><ul><li class="half_rhythm"><div>Molecular genetic testing if the pathogenic variants in the family are known;</div></li><li class="half_rhythm"><div>Consideration of motor nerve conduction velocities and nerve biopsy if the pathogenic variants in the family are not known.</div></li></ul><p>See <a href="#cmt4c.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="cmt4c.Pregnancy_Management"><h3>Pregnancy Management</h3><p>CMT appears to be an independent risk factor for complications during pregnancy and delivery.</p><ul><li class="half_rhythm"><div>The symptoms of CMT can worsen during pregnancy; in particular: cramps, subjective sensitivity (e.g., paresthesias), difficulty walking, and fatigue.</div></li><li class="half_rhythm"><div>In rare cases, crises occurring during pregnancy do not subside post partum.</div></li><li class="half_rhythm"><div>A retrospective study in Norway between 1967 and 2002 comparing 108 births to mothers with CMT with 2.1 million births to mothers without CMT determined that mothers with CMT more frequently needed interventions during delivery [<a class="bk_pop" href="#cmt4c.REF.hoff.2005.459">Hoff et al 2005</a>]. Bleeding post partum was also more common in mothers with CMT.</div></li><li class="half_rhythm"><div>It has been postulated that fetal presentation tends to be abnormal because of the combination of CMT in the mother and fetus [<a class="bk_pop" href="#cmt4c.REF.rayl.1996.28">Rayl et al 1996</a>, <a class="bk_pop" href="#cmt4c.REF.hoff.2005.459">Hoff et al 2005</a>].</div></li></ul></div><div id="cmt4c.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>See <a class="bk_pop" href="#cmt4c.REF.grandis.2005.23">Grandis &#x00026; Shy [2005]</a>.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder</p></div><div id="cmt4c.Other"><h3>Other</h3><p><b>Career and employment</b> may be influenced by persistent weakness of hands and/or feet.</p><p><b>Anesthesia.</b> Relatively few studies reported in the literature address risks of anesthesia in patients with CMT. No complications were observed after anesthesia in a large cohort followed in specialized consultation, but the advice of the anesthesiologist should be followed.</p><ul><li class="half_rhythm"><div>Although it had no adverse effects in 41 persons with CMT [<a class="bk_pop" href="#cmt4c.REF.antognini.1992.398">Antognini 1992</a>], use of succinylcholine for general anesthesia is usually contraindicated.</div></li><li class="half_rhythm"><div>Blockers of the neuromuscular junction should be used with caution.</div></li><li class="half_rhythm"><div>Local-regional anesthesia, especially epidural analgesia at child birth, has been used without problems in CMT. This use of anesthesia should be discussed on a case-by-case basis with the anesthesiologist.</div></li></ul></div></div><div id="cmt4c.Genetic_Counseling"><h2 id="_cmt4c_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="cmt4c.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Charcot-Marie-Tooth neuropathy type 4C (CMT4C) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="cmt4c.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (i.e., carriers of one <i>SH3TC2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Once an at-risk sib is known to be unaffected, the risk of his/her being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>SH3TC2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is 2/3.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with CMT4C are obligate heterozygotes (carriers) for an <i>SH3TC2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each sib of the proband's parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>SH3TC2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a></p></div><div id="cmt4c.Carrier_Heterozygotes_Detection"><h3>Carrier (Heterozygotes) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>SH3TC2</i> pathogenic variants in the family.</p></div><div id="cmt4c.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#cmt4c.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="cmt4c.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Testing</h3><p>Once the <i>SH3TC2</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-testing/">preimplantation genetic testing</a> for CMT4C are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="cmt4c.Resources"><h2 id="_cmt4c_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Charcot-Marie-Tooth Association (CMTA)</b></div><div>PO Box 105</div><div>Glenolden PA 19036</div><div><b>Phone:</b> 800-606-2682 (toll-free); 610-499-9264</div><div><b>Fax:</b> 610-499-9267</div><div><b>Email:</b> info@cmtausa.org</div><div><a href="http://www.cmtausa.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cmtausa.org</a></div></li><li class="half_rhythm"><div><b>European Charcot-Marie-Tooth Consortium</b></div><div>Department of Molecular Genetics</div><div>University of Antwerp</div><div>Antwerp Antwerpen B-2610</div><div>Belgium</div><div><b>Fax:</b> 03 2651002</div><div><b>Email:</b> gisele.smeyers@ua.ac.be</div></li><li class="half_rhythm"><div><b>Hereditary Neuropathy Foundation, Inc.</b></div><div>432 Park Avenue South</div><div>4th Floor</div><div>New York NY 10016</div><div><b>Phone:</b> 855-435-7268 (toll-free); 212-722-8396</div><div><b>Fax:</b> 917-591-2758</div><div><b>Email:</b> info@hnf-cure.org</div><div><a href="http://www.hnf-cure.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.hnf-cure.org</a></div></li><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Charcot%20Marie%20Tooth%20disease&#x00026;parent=Genetic%20Syndromes&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Charcot Marie Tooth disease</a></div></li><li class="half_rhythm"><div><b>NCBI Genes and Disease</b></div><div><a href="/books/NBK22241/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Charcot-Marie-Tooth syndrome</a></div></li><li class="half_rhythm"><div><b>TREAT-NMD</b></div><div>Institute of Genetic Medicine</div><div>University of Newcastle upon Tyne </div><div>International Centre for Life </div><div> Newcastle upon Tyne NE1 3BZ</div><div>United Kingdom</div><div><b>Phone:</b> 44 (0)191 241 8617</div><div><b>Fax:</b> 44 (0)191 241 8770</div><div><b>Email:</b> info@treat-nmd.eu</div><div><a href="http://www.treat-nmd.eu/cmt/overview/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Charcot-Marie-Tooth Disease</a></div></li><li class="half_rhythm"><div><b>Association Francaise contre les Myopathies (AFM)</b></div><div>1 Rue de l'International</div><div>BP59</div><div>Evry cedex 91002</div><div>France</div><div><b>Phone:</b> +33 01 69 47 28 28</div><div><b>Email:</b> dmc@afm.genethon.fr</div><div><a href="http://www.afm-telethon.fr" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.afm-telethon.fr </a></div></li><li class="half_rhythm"><div><b>European Neuromuscular Centre (ENMC)</b></div><div>Lt Gen van Heutszlaan 6</div><div>3743 JN Baarn</div><div>Netherlands</div><div><b>Phone:</b> 31 35 5480481</div><div><b>Fax:</b> 31 35 5480499</div><div><b>Email:</b> enmc@enmc.org</div><div><a href="http://www.enmc.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.enmc.org</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy Association - USA (MDA)</b></div><div>222 South Riverside Plaza</div><div>Suite 1500</div><div>Chicago IL 60606</div><div><b>Phone:</b> 800-572-1717</div><div><b>Email:</b> mda@mdausa.org</div><div><a href="http://www.mda.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mda.org</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy UK</b></div><div>61A Great Suffolk Street</div><div>London SE1 0BU </div><div>United Kingdom</div><div><b>Phone:</b> 0800 652 6352 (toll-free); 020 7803 4800</div><div><b>Email:</b> info@musculardystrophyuk.org</div><div><a href="http://www.musculardystrophyuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.musculardystrophyuk.org</a></div></li><li class="half_rhythm"><div><b>RDCRN Patient Contact Registry: Inherited Neuropathies Consortium</b></div><div><a href="https://www.rarediseasesnetwork.org/cms/inc" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Patient Contact Registry</a></div></li></ul></div><div id="cmt4c.Molecular_Genetics"><h2 id="_cmt4c_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="cmt4c.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Charcot-Marie-Tooth Neuropathy Type 4C: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1340/table/cmt4c.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cmt4c.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_cmt4c.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Locus Name</th><th id="hd_b_cmt4c.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_cmt4c.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_cmt4c.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_cmt4c.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_cmt4c.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_cmt4c.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_cmt4c.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">CMT4C</td><td headers="hd_b_cmt4c.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/79628" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SH3TC2</i></a></td><td headers="hd_b_cmt4c.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=79628" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">5q32</a></td><td headers="hd_b_cmt4c.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q8TF17" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SH3 domain and tetratricopeptide repeat-containing protein 2</a></td><td headers="hd_b_cmt4c.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.molgen.ua.ac.be/CMTMutations/Mutations/Contexts.cfm?ID=29" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">IPN Mutations, SH3TC2</a><br /><a href="https://databases.lovd.nl/shared/genes/SH3TC2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SH3TC2 homepage - Leiden Muscular Dystrophy pages</a></td><td headers="hd_b_cmt4c.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SH3TC2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SH3TC2</a></td><td headers="hd_b_cmt4c.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SH3TC2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SH3TC2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="cmt4c.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="cmt4c.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Charcot-Marie-Tooth Neuropathy Type 4C (<a href="/omim/601596,608206" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1340/table/cmt4c.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cmt4c.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601596" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601596</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608206" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608206</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SH3 DOMAIN AND TETRATRICOPEPTIDE REPEAT DOMAIN 2; SH3TC2</td></tr></tbody></table></div></div><p><b>Gene structure.</b> The normal <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> comprises 17 coding exons spanning 62 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> sequence. For a detailed summary of gene and protein information, see <a href="/books/NBK1340/#cmt4c.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> To date, more than 60 pathogenic variants including numerous <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, frameshift, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants have been reported [<a class="bk_pop" href="#cmt4c.REF.senderek.2003.1106">Senderek et al 2003</a>, <a class="bk_pop" href="#cmt4c.REF.azzedine.a">Azzedine et al 2005a</a>, <a class="bk_pop" href="#cmt4c.REF.azzedine.b">Azzedine et al 2005b</a>, <a class="bk_pop" href="#cmt4c.REF.azzedine.2006.602">Azzedine et al 2006</a>, <a class="bk_pop" href="#cmt4c.REF.colomer.2006.449">Colomer et al 2006</a>,<a class="bk_pop" href="#cmt4c.REF.houlden.2009.264">Houlden et al 2009</a>, <a class="bk_pop" href="#cmt4c.REF.baets.2011.2664">Baets et al 2011</a>, <a class="bk_pop" href="#cmt4c.REF.la__uthov_.2011.334">La&#x00161;&#x00161;uthov&#x000e1; et al 2011</a>, <a class="bk_pop" href="#cmt4c.REF.fischer.2012.515">Fischer et la 2012</a>, <a class="bk_pop" href="#cmt4c.REF.yger.2012.112">Yger et al 2012</a>] (see <a class="figpopup" href="/books/NBK1340/table/cmt4c.T.select_sh3tc2_pathogenic_variant/?report=objectonly" target="object" rid-figpopup="figcmt4cTselectsh3tc2pathogenicvariant" rid-ob="figobcmt4cTselectsh3tc2pathogenicvariant">Table 4</a>).</p><div id="cmt4c.T.select_sh3tc2_pathogenic_variant" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Select <i>SH3TC2</i> Pathogenic Variants Relevant to This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1340/table/cmt4c.T.select_sh3tc2_pathogenic_variant/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cmt4c.T.select_sh3tc2_pathogenic_variant_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.28delG<br />(26delG)</td><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu10SerfsTer4<br />(Arg9fs)</td><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_3" rowspan="20" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?val=NM_024577.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_024577<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/entrez/viewer.fcgi?val=NP_078853.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_078853<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.217_227delGCTGCTCGGAGinsCCAGTAA</td><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala73ProfsTer55</td></tr><tr><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.530-2A&#x0003e;G</td><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--&#x000a0;<sup>2</sup></td></tr><tr><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.920G&#x0003e;A</td><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp307Ter</td></tr><tr><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1178-1G&#x0003e;A</td><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--&#x000a0;<sup>2</sup></td></tr><tr><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1586G&#x0003e;A</td><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg529Gln</td></tr><tr><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1747_1748delAG</td><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg583AlafsTer4</td></tr><tr><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1969G&#x0003e;A</td><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu657Lys</td></tr><tr><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1972C&#x0003e;T</td><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg658Cys</td></tr><tr><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1982T&#x0003e;C</td><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu662Pro</td></tr><tr><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2191delG</td><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu731LysfsTer20</td></tr><tr><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2491_2492delAG</td><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu832HisfsTer8</td></tr><tr><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2642A&#x0003e;T</td><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn881Ser</td></tr><tr><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2710C&#x0003e;T</td><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg904Ter</td></tr><tr><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2829T&#x0003e;G</td><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr943Ter</td></tr><tr><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2860C&#x0003e;T</td><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg954Ter</td></tr><tr><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.3325C&#x0003e;T</td><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg1109Ter</td></tr><tr><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.3326G&#x0003e;C</td><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg1109Pro</td></tr><tr><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.3341delC</td><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro1114LeufsTer2</td></tr><tr><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.3601C&#x0003e;T</td><td headers="hd_h_cmt4c.T.select_sh3tc2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln1201Ter</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt></dt><dd><div><p class="no_margin">For frameshift variants, "Ter#" indicates the codon position in the new reading frame that ends in a stop (Ter). The position of the stop in the new reading frame is calculated starting at the first changed amino acid that is created by the frameshift (e.g., p.Glu10Ser) and ending at the first stop codon (Ter#), e.g., p.Glu10SerfsTer4). The shifted reading frame is thus open for "#-1" amino acids (thus in p.Glu10SerfsTer4, the new reading frame is open for three more codons, therefore terminating at codon 13).</p></div></dd><dt>1. </dt><dd><div id="cmt4c.TF.4.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd><dt>2. </dt><dd><div id="cmt4c.TF.4.2"><p class="no_margin">Because the splice donor or splice acceptor site is changed, the change is expected to affect <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> (the nomenclature designation is r.spl?).</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The protein, known as the SH3 <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> and tetratricopeptide repeats containing protein 2 (SH3TC2), comprises 1,287 amino acids. The SH3TC2 protein has been reported to contain Src homology-3 (SH3) domains and tetratricopeptide repeat (TPR) domains; however, the predicted number and location of these domains varies [<a class="bk_pop" href="#cmt4c.REF.roberts.2010.1009">Roberts et al 2010</a>].</p><p>SH3 domains are highly conserved in eukaryotes, prokaryotes, and viruses, and mediate interactions with enzymes (tyrosine kinases, phospholipases c&#x003b3;<sub>1</sub> [PLC&#x003b3;<sub>1</sub>] and PLC&#x003b3;<sub>2</sub>, phosphoinositide 3-kinase and the NADPH-oxidase complex), cytoskeleton molecules (spectrin and nebulin), and myosins. They play important roles in cell-cell communication and signal transduction from the cell surface to the nucleus [<a class="bk_pop" href="#cmt4c.REF.whisstock.1999.132">Whisstock &#x00026; Lesk 1999</a>].Proteins with TPR domains are involved in many cellular processes through protein-protein interactions: in mitosis and RNA synthesis by their association in multiprotein complexes controlling cell-cycle or transcription machinery, in protein transport, and in chaperon functions [<a class="bk_pop" href="#cmt4c.REF.blatch.1999.932">Blatch &#x00026; Lassle 1999</a>]. The spectrum of possible functions mediated by the TPR and SH3 domains is therefore large.</p><p>Studies in the knockout mouse model have demonstrated that Sh3tc2 is required for normal myelination in the peripheral nerve [<a class="bk_pop" href="#cmt4c.REF.arnaud.2009.17528">Arnaud et al 2009</a>]. The localization of Sh3tc2 protein Schwann cells in mouse (at the plasma membrane and endocytic recycling compartment) and rat (to intracellular tubulo-vesicular structures concentrated near the nucleus but distributed throughout the cell) are consistent with loss of <i>Sh3tc2</i> resulting in a demyelinating neuropathy [<a class="bk_pop" href="#cmt4c.REF.arnaud.2009.17528">Arnaud et al 2009</a>, <a class="bk_pop" href="#cmt4c.REF.roberts.2010.1009">Roberts et al 2010</a>]. Studies of truncated proteins in HeLa cells demonstrated that proteins truncated for the first 100 amino acids preceding the SH3 <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> or the last 200 amino acids following the last TPR domain are sufficient to delocalize the protein from the recycling endosome so that the protein remains cytosolic.</p><p>SH3TC2 protein binds to the active form of the small GTPase Rab11, a protein that regulates the recycling of internalized proteins and membrane back to the surface, but not with Rab5, an early endosome GTPase. The authors suggest that SH3TC2 is a Rab11 effector involved in endocytic protein recycling regulation [<a class="bk_pop" href="#cmt4c.REF.roberts.2010.1009">Roberts et al 2010</a>]. More recently, <a class="bk_pop" href="#cmt4c.REF.gouttenoire.2013.1041">Gouttenoire et al [2013]</a> demonstrated that SH3TC2 interacts via its N-terminal region with ErbB2 (receptor tyrosine-protein kinase) and interferes with its intracellular trafficking from the plasma membrane on neuronal neuregulin 1 (Nrg1) activation. Interestingly, SH3 and TPR domains do not interfere in such interaction.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Most pathogenic variants in <i>SH3TC2</i> lead to loss or truncation of the protein, compatible with loss of function in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disease. Pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants have been identified in inter-TPR regions [<a class="bk_pop" href="#cmt4c.REF.roberts.2010.1009">Roberts et al 2010</a>]. Other constructs harboring disease-associated missense variants have also been shown to result in protein mislocalization in HeLa cells.</p><p>Sh3tc2 knockout mouse models show hypomyelination in peripheral nerves and wider nodes of Ranvier, while the paranodal structure remains unscathed. Nodes of Ranvier of individuals with CMT4C show similar changes in the nodes [<a class="bk_pop" href="#cmt4c.REF.arnaud.2009.17528">Arnaud et al 2009</a>].</p></div><div id="cmt4c.References"><h2 id="_cmt4c_References_">References</h2><div id="cmt4c.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.abresch.2002.39">Abresch RT, Carter GT, Jensen MP, Kilmer DD. Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease. <span><span class="ref-journal">Am J Hosp Palliat Care. </span>2002;<span class="ref-vol">19</span>:39–48.</span> [<a href="/pubmed/12173612" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12173612</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.antognini.1992.398">Antognini JF. Anaesthesia for Charcot-Marie-Tooth disease: a review of 86 cases. <span><span class="ref-journal">Can J Anaesth. </span>1992;<span class="ref-vol">39</span>:398–400.</span> [<a href="/pubmed/1563065" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1563065</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.arnaud.2009.17528">Arnaud E, Zenker J, de Preux Charles AS, Stendel C, Roos A, M&#x000e9;dard JJ, Tricaud N, Kleine H, Luscher B, Weis J, Suter U, Senderek J, Chrast R. SH3TC2/KIAA1985 protein is required for proper myelination and the integrity of the node of Ranvier in the peripheral nervous system. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2009;<span class="ref-vol">106</span>:17528–33.</span> [<a href="/pmc/articles/PMC2765159/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2765159</span></a>] [<a href="/pubmed/19805030" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19805030</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.azzedine.a">Azzedine H, Ravis&#x000e9; N, Tazir M, Gabre&#x000eb;ls-Festens A, Lammens M, Dubourg O, Senderek J, Verny C, Brice A, Grid D, Birouk N, LeGuern E. Eight new mutations of the KIAA1985 gene associated with severe form of demyelinating autosomal recessive Charcot-Marie-Tooth disease (CMT4C) in 11 families and founder effects in families North African and European origin. Prague, Czech Republic: 37th Annual Meeting of the European Society of Human Genetics. 2005a.</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.azzedine.2006.602">Azzedine H, Ravis&#x000e9; N, Verny C, Gabre&#x000eb;ls-Festen A, Lammens M, Grid D, Vallat JM, Durosier G, Senderek J, Nouioua S, Hamadouche T, Bouhouche A, Guilbot A, Stendel C, Ruberg M, Brice A, Birouk N, Dubourg O, Tazir M, LeGuern E. Spine deformities in Charcot-Marie-Tooth 4C caused by SH3TC2 gene mutations. <span><span class="ref-journal">Neurology. </span>2006;<span class="ref-vol">67</span>:602–6.</span> [<a href="/pubmed/16924012" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16924012</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.azzedine.b">Azzedine H, Verny C, Tazir M, Gabre&#x000eb;ls-Festen A, Birouk N, Dubourg O, Senderek J, Ravis&#x000e9; N, Grid D, Brice A, LeGuern E. Eight new mutations in the KIAA1985 gene associated with severe form of demyelinating autosomal recessive Charcot-Marie-Tooth disease (CMT4C) in 11 families and founder effect in north African and European families. Miami Beach, FL: 57th Annual Meeting of the American Academy of Neurology. 2005b.</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.baets.2011.2664">Baets J, Deconinck T, De Vriendt E, Zimo&#x00144; M, Yperzeele L, Van Hoorenbeeck K, Peeters K, Spiegel R, Parman Y, Ceulemans B, Van Bogaert P, Pou-Serradell A, Bernert G, Dinopoulos A, Auer-Grumbach M, Sallinen SL, Fabrizi GM, Pauly F, Van den Bergh P, Bilir B, Battaloglu E, Madrid RE, Kabzi&#x00144;ska D, Kochanski A, Topaloglu H, Miller G, Jordanova A, Timmerman V, De Jonghe P. Genetic spectrum of hereditary neuropathies with onset in the first year of life. <span><span class="ref-journal">Brain. </span>2011;<span class="ref-vol">134</span>:2664–76.</span> [<a href="/pmc/articles/PMC3170533/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3170533</span></a>] [<a href="/pubmed/21840889" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21840889</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.birouk.2003.598">Birouk N, Azzedine H, Dubourg O, Muriel M-P, Benomar A, Hamadouche T, Maisonobe T, Ouazzani R, Brice A, Yahyaoui M, Chkili T, LeGuern E. Phenotypical features of a Moroccan family with autosomal recessive Charcot-Marie-Tooth disease associated with the S194X mutation in the GDAP1 gene. <span><span class="ref-journal">Arch. Neurol. </span>2003;<span class="ref-vol">60</span>:598–604.</span> [<a href="/pubmed/12707075" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12707075</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.blatch.1999.932">Blatch GL, Lassle M. The tetratricopeptide repeat: a structural motif mediating protein-protein interactions. <span><span class="ref-journal">Bioessays. </span>1999;<span class="ref-vol">21</span>:932–9.</span> [<a href="/pubmed/10517866" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10517866</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.bouhouche.2007.1062">Bouhouche A, Birouk N, Azzedine H, Benomar A, Durosier G, Ente D, Muriel MP, Ruberg M, Slassi I, Yahyaoui M, Dubourg O, Ouazzani R, LeGuern E. Autosomal recessive axonal Charcot-Marie-Tooth disease (ARCMT2): phenotype-genotype correlations in 13 Moroccan families. <span><span class="ref-journal">Brain. </span>2007;<span class="ref-vol">130</span>:1062–75.</span> [<a href="/pubmed/17347251" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17347251</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.burgunder.2011.207">Burgunder JM, Sch&#x000f6;ls L, Baets J, Andersen P, Gasser T, Szolnoki Z, Fontaine B, Van Broeckhoven C, Di Donato S, De Jonghe P, Lynch T, Mariotti C, Spinazzola A, Tabrizi SJ, Tallaksen C, Zeviani M, Harbo HF, Finsterer J. EFNS. EFNS guidelines for the molecular diagnosis of neurogenetic disorders: motoneuron, peripheral nerve and muscle disorders. <span><span class="ref-journal">Eur J Neurol. </span>2011;<span class="ref-vol">18</span>:207–17.</span> [<a href="/pubmed/20500522" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20500522</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.carter.1998.1560">Carter GT, Jensen MP, Galer BS, Kraft GH, Crabtree LD, Beardsley RM, Abresch RT, Bird TD. Neuropathic pain in Charcot-Marie-Tooth disease. <span><span class="ref-journal">Arch Phys Med Rehabil. </span>1998;<span class="ref-vol">79</span>:1560–4.</span> [<a href="/pubmed/9862301" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9862301</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.claramunt.2005.358">Claramunt R, Pedrola L, Sevilla T, Lopez de Munain A, Berciano J, Cuesta A, Sanchez-Navarro B, Millan JM, Saifi GM, Lupski JR, Vilchez JJ, Espinos C, Palau F. Genetics of Charcot-Marie-Tooth disease type 4A: mutations, inheritance, phenotypic variability, and founder effect. <span><span class="ref-journal">J. Med. Genet. </span>2005;<span class="ref-vol">42</span>:358–65.</span> (Letter) [<a href="/pmc/articles/PMC1736030/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1736030</span></a>] [<a href="/pubmed/15805163" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15805163</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.colomer.2006.449">Colomer J, Gooding R, Angelicheva D, King RH, Guillen-Navarro E, Parman Y, Nascimento A, Conill J, Kalaydjieva L. Clinical spectrum of CMT4C disease in patients homozygous for the p.Arg1109X mutation in SH3TC2. <span><span class="ref-journal">Neuromuscul Disord. </span>2006;<span class="ref-vol">16</span>:449–53.</span> [<a href="/pubmed/16806930" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16806930</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.echanizlaguna.2013.1523">Echaniz-Laguna A, Ghezzi D, Chassagne M, Mayen&#x000e7;on M, Padet S, Melchionda L, Rouvet I, Lannes B, Bozon D, Latour P, Zeviani M, Mousson de Camaret B. SURF1 deficiency causes demyelinating Charcot-Marie-Tooth disease. <span><span class="ref-journal">Neurology. </span>2013;<span class="ref-vol">81</span>:1523–30.</span> [<a href="/pmc/articles/PMC3888171/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3888171</span></a>] [<a href="/pubmed/24027061" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24027061</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.fischer.2012.515">Fischer C, Trajanoski S, Papi&#x00107; L, Windpassinger C, Bernert G, Freilinger M, Schabh&#x000fc;ttl M, Arslan-Kirchner M, Javaher-Haghighi P, Plecko B, Senderek J, Rauscher C, L&#x000f6;scher WN, Pieber TR, Janecke AR, Auer-Grumbach M. SNP array-based whole genome homozygosity mapping as the first step to a molecular diagnosis in patients with Charcot-Marie-Tooth disease. <span><span class="ref-journal">J Neurol. </span>2012;<span class="ref-vol">259</span>:515–23.</span> [<a href="/pmc/articles/PMC3296015/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3296015</span></a>] [<a href="/pubmed/21892769" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21892769</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.gabre_lsfesten.1999.569">Gabre&#x000eb;ls-Festen A, van Beersum S, Eshuis L, LeGuern E, Gabre&#x000eb;ls F, van Engelen B, Mariman E. Study on the gene and phenotypic characterisation of autosomal recessive demyelinating motor and sensory neuropathy (Charcot-Marie-Tooth disease) with a gene locus on chromosome 5q23-q33. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>1999;<span class="ref-vol">66</span>:569–74.</span> [<a href="/pmc/articles/PMC1736348/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1736348</span></a>] [<a href="/pubmed/10209165" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10209165</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.gooding.2005.e69">Gooding R, Colomer J, King R, Angelicheva D, Marns L, Parman Y, Chandler D, Bertranpetit J, Kalaydjieva L. A novel Gypsy founder mutation, p.Arg1109X in the CMT4C gene, causes variable peripheral neuropathy phenotypes. <span><span class="ref-journal">J Med Genet. </span>2005;<span class="ref-vol">42</span>:e69</span> [<a href="/pmc/articles/PMC1735969/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735969</span></a>] [<a href="/pubmed/16326826" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16326826</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.gosselin.2008.483">Gosselin I, Thiffault I, T&#x000e9;treault M, Chau V, Dicaire MJ, Loisel L, Emond M, Senderek J, Mathieu J, Dupr&#x000e9; N, Vanasse M, Puymirat J, Brais B. Founder SH3TC2 mutations are responsible for a CMT4C French-Canadians cluster. <span><span class="ref-journal">Neuromuscul Disord. </span>2008;<span class="ref-vol">18</span>:483–92.</span> [<a href="/pubmed/18511281" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18511281</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.gouttenoire.2013.1041">Gouttenoire EA, Lupo V, Calpena E, Bartesaghi L, Sch&#x000fc;pfer F, M&#x000e9;dard JJ, Maurer F, Beckmann JS, Senderek J, Palau F, Espin&#x000f3;s C, Chrast R. Sh3tc2 deficiency affects neuregulin-1/ErbB signaling. <span><span class="ref-journal">Glia. </span>2013;<span class="ref-vol">61</span>:1041–51.</span> [<a href="/pubmed/23553667" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23553667</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.grandis.2005.23">Grandis M, Shy ME. Current therapy for Charcot-Marie-Tooth disease. <span><span class="ref-journal">Curr Treat Options Neurol. </span>2005;<span class="ref-vol">7</span>:23–31.</span> [<a href="/pubmed/15610704" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15610704</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.guilbot.1999.453">Guilbot A, Kessali M, Ravis&#x000e9; N, Hammadouche T, Bouhouche A, Maisonobe T, Grid D, Brice A, LeGuern E. The autosomal recessive form of CMT disease linked to 5q31-q33. <span><span class="ref-journal">Ann N Y Acad Sci. </span>1999;<span class="ref-vol">883</span>:453–6.</span> [<a href="/pubmed/10586271" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10586271</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.guyton.2000.317">Guyton GP, Mann RA. The pathogenesis and surgical management of foot deformity in Charcot-Marie-Tooth disease. <span><span class="ref-journal">Foot Ankle Clin. </span>2000;<span class="ref-vol">5</span>:317–26.</span> [<a href="/pubmed/11232233" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11232233</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.hahn.1991.230">Hahn AF, Parkes AW, Bolton CF, Stewart SA. Neuromyotonia in hereditary motor neuropathy. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>1991;<span class="ref-vol">54</span>:230–5.</span> [<a href="/pmc/articles/PMC1014391/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1014391</span></a>] [<a href="/pubmed/1851512" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1851512</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.hoff.2005.459">Hoff JM, Gilhus NE, Daltveit AK. Pregnancies and deliveries in patients with Charcot-Marie-Tooth disease. <span><span class="ref-journal">Neurology. </span>2005;<span class="ref-vol">64</span>:459–62.</span> [<a href="/pubmed/15699375" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15699375</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.houlden.2009.264">Houlden H, Laura M, Ginsberg L, Jungbluth H, Robb SA, Blake J, Robinson S, King RH, Reilly MM. The phenotype of Charcot-Marie-Tooth disease type 4C due to SH3TC2 mutations and possible predisposition to an inflammatory neuropathy. <span><span class="ref-journal">Neuromuscul Disord. </span>2009;<span class="ref-vol">19</span>:264–9.</span> [<a href="/pubmed/19272779" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19272779</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.howard.2002.384">Howard HC, Mount DB, Rochefort D, Byun N, Dupr&#x000e9; N, Lu J, Fan X, Song L, Rivi&#x000e8;re JB, Pr&#x000e9;vost C, Horst J, Simonati A, Lemcke B, Welch R, England R, Zhan FQ, Mercado A, Siesser WB, George AL Jr, McDonald MP, Bouchard JP, Mathieu J, Delpire E, Rouleau GA. The K-Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum. <span><span class="ref-journal">Nat Genet. </span>2002;<span class="ref-vol">32</span>:384–92.</span> [<a href="/pubmed/12368912" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12368912</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.iguchi.2013.283">Iguchi M, Hashiguchi A, Ito E, Toda K, Urano M, Shimizu Y, Takeuchi C, Saito K, Takashima H, Uchiyama S. Charcot-Marie-Tooth disease type 4C in Japan: report of a case. <span><span class="ref-journal">Muscle Nerve. </span>2013;<span class="ref-vol">47</span>:283–6.</span> [<a href="/pubmed/23281072" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23281072</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.kessali.1997.867">Kessali M, Zemmouri R, Guilbot A, Maisonobe T, Brice A, LeGuern E, Grid D. A clinical, electrophysiologic, neuropathologic, and genetic study of two large Algerian families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease. <span><span class="ref-journal">Neurology. </span>1997;<span class="ref-vol">48</span>:867–73.</span> [<a href="/pubmed/9109869" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9109869</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.la__uthov_.2011.334">La&#x00161;&#x00161;uthov&#x000e1; P, Mazanec R, Vondr&#x000e1;&#x0010d;ek P, Si&#x00161;kov&#x000e1; D, Haberlov&#x000e1; J, Sabov&#x000e1; J, Seeman P. High frequency of SH3TC2 mutations in Czech HMSN I patients. <span><span class="ref-journal">Clin Genet. </span>2011;<span class="ref-vol">80</span>:334–45.</span> [<a href="/pubmed/21291453" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21291453</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.leguern.1996.1685">LeGuern E, Guilbot A, Kessali M, Ravis&#x000e9; N, Tassin J, Maisonobe T, Grid D, Brice A. Homozygosity mapping of an autosomal recessive form of demyelinating Charcot-Marie-Tooth disease to chromosome 5q23-q33. <span><span class="ref-journal">Hum Mol Genet. </span>1996;<span class="ref-vol">5</span>:1685–8.</span> [<a href="/pubmed/8894708" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8894708</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.murphy.2012.706">Murphy SM, Laura M, Fawcett K, Pandraud A, Liu YT, Davidson GL, Rossor AM, Polke JM, Castleman V, Manji H, Lunn MP, Bull K, Ramdharry G, Davis M, Blake JC, Houlden H, Reilly MM. Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2012;<span class="ref-vol">83</span>:706–10.</span> [<a href="/pmc/articles/PMC3736805/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3736805</span></a>] [<a href="/pubmed/22577229" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22577229</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.nelis.2002.1865">Nelis E, Erdem S, Van Den Bergh PY, Belpaire-Dethiou MC, Ceuterick C, Van Gerwen V, Cuesta A, Pedrola L, Palau F, Gabre&#x000eb;ls-Festen AA, Verellen C, Tan E, Demirci M, Van Broeckhoven C, De Jonghe P, Topaloglu H, Timmerman V. Mutations in GDAP1: autosomal recessive CMT with demyelination and axonopathy. <span><span class="ref-journal">Neurology. </span>2002;<span class="ref-vol">59</span>:1865–72.</span> [<a href="/pubmed/12499475" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12499475</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.padua.2008.193">Padua L, Cavallaro T, Pareyson D, Quattrone A, Vita G, Schenone A, Italian CMT. QoL Study Group. Charcot-Marie-Tooth and pain: correlations with neurophysiological, clinical, and disability findings. <span><span class="ref-journal">Neurol Sci. </span>2008;<span class="ref-vol">29</span>:193–4.</span> [<a href="/pubmed/18612771" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18612771</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.parman.2004.2540">Parman Y, Battaloglu E, Baris I, Bilir B, Poyraz M, Bissar-Tadmouri N, Williams A, Ammar N, Nelis E, Timmerman V, De Jonghe P, Najafov A, Deymeer F, Serdaroglu P, Brophy PJ, Said G. Clinicopathological and genetic study of early-onset demyelinating neuropathy. <span><span class="ref-journal">Brain. </span>2004;<span class="ref-vol">127</span>:2540–50.</span> [<a href="/pubmed/15469949" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15469949</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.rayl.1996.28">Rayl J, Gibson PJ, Hickok DE. A population-based case-control study of risk factors for breech presentation. <span><span class="ref-journal">Am J Obstet Gynecol. </span>1996;<span class="ref-vol">174</span>:28–32.</span> [<a href="/pubmed/8572022" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8572022</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.roberts.2010.1009">Roberts RC, Peden AA, Buss F, Bright NA, Latouche M, Reilly MM, Kendrick-Jones J, Luzio JP. Mistargeting of SH3TC2 away from the recycling endosome causes Charcot-Marie-Tooth disease type 4C. <span><span class="ref-journal">Hum Mol Genet. </span>2010;<span class="ref-vol">19</span>:1009–18.</span> [<a href="/pmc/articles/PMC2830826/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2830826</span></a>] [<a href="/pubmed/20028792" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20028792</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.senderek.2003.1106">Senderek J, Bergmann C, Stendel C, Kirfel J, Verpoorten N, De Jonghe P, Timmerman V, Chrast R, Verheijen MH, Lemke G, Battaloglu E, Parman Y, Erdem S, Tan E, Topaloglu H, Hahn A, Muller-Felber W, Rizzuto N, Fabrizi GM, Stuhrmann M, Rudnik-Schoneborn S, Zuchner S, Michael Schroder J, Buchheim E, Straub V, Klepper J, Huehne K, Rautenstrauss B, Buttner R, Nelis E, Zerres K. Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy. <span><span class="ref-journal">Am J Hum Genet. </span>2003;<span class="ref-vol">73</span>:1106–19.</span> [<a href="/pmc/articles/PMC1180490/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1180490</span></a>] [<a href="/pubmed/14574644" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14574644</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.szigeti.2007.257">Szigeti K, Wiszniewski W, Saifi GM, Sherman DL, Sule N, Adesina AM, Mancias P, Papasozomenos SCh, Miller G, Keppen L, Daentl D, Brophy PJ, Lupski JR. Functional, histopathologic and natural history study of neuropathy associated with EGR2 mutations. <span><span class="ref-journal">Neurogenetics. </span>2007;<span class="ref-vol">8</span>:257–62.</span> [<a href="/pubmed/17717711" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17717711</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.tiffreau.2006.756">Tiffreau V, Viet G, Th&#x000e9;venon A. Pain and neuromuscular disease: the results of a survey. <span><span class="ref-journal">Am J Phys Med Rehabil. </span>2006;<span class="ref-vol">85</span>:756–66.</span> [<a href="/pubmed/16924188" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16924188</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.whisstock.1999.132">Whisstock JC, Lesk AM. SH3 domains in prokaryotes. <span><span class="ref-journal">Trends Biochem Sci. </span>1999;<span class="ref-vol">24</span>:132–3.</span> [<a href="/pubmed/10322416" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10322416</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.yger.2012.112">Yger M, Stojkovic T, Tardieu S, Maisonobe T, Brice A, Echaniz-Laguna A, Alembik Y, Girard S, Cazeneuve C, Leguern E, Dubourg O. Characteristics of clinical and electrophysiological pattern of Charcot-Marie-Tooth 4C. <span><span class="ref-journal">J Peripher Nerv Syst. </span>2012;<span class="ref-vol">17</span>:112–22.</span> [<a href="/pubmed/22462672" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22462672</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.ylikallio.2013.2975">Ylikallio E, P&#x000f6;yh&#x000f6;nen R, Zimon M, De Vriendt E, Hilander T, Paetau A, Jordanova A, L&#x000f6;nnqvist T, Tyynismaa H. Deficiency of the E3 ubiquitin ligase TRIM2 in early-onset axonal neuropathy. <span><span class="ref-journal">Hum Mol Genet. </span>2013;<span class="ref-vol">22</span>:2975–83.</span> [<a href="/pubmed/23562820" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23562820</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt4c.REF.zimo_.2012.1080">Zimo&#x00144; M, Baets J, Almeida-Souza L, De Vriendt E, Nikodinovic J, Parman Y, Battalo&#x0011f;lu E, Matur Z, Guergueltcheva V, Tournev I, Auer-Grumbach M, De Rijk P, Petersen BS, M&#x000fc;ller T, Fransen E, Van Damme P, L&#x000f6;scher WN, Bari&#x00161;i&#x00107; N, Mitrovic Z, Previtali SC, Topalo&#x0011f;lu H, Bernert G, Beleza-Meireles A, Todorovic S, Savic-Pavicevic D, Ishpekova B, Lechner S, Peeters K, Ooms T, Hahn AF, Z&#x000fc;chner S, Timmerman V, Van Dijck P, Rasic VM, Janecke AR, De Jonghe P, Jordanova A. Loss-of-function mutations in HINT1 cause axonal neuropathy with neuromyotonia. <span><span class="ref-journal">Nat Genet. </span>2012;<span class="ref-vol">44</span>:1080–3.</span> [<a href="/pubmed/22961002" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22961002</span></a>]</div></li></ul></div></div><div id="cmt4c.Chapter_Notes"><h2 id="_cmt4c_Chapter_Notes_">Chapter Notes</h2><div id="cmt4c.Acknowledgments"><h3>Acknowledgments</h3><p>This work was supported by the <i>Association Fran&#x000e7;aise contre les Myopathies</i> (AFM).</p></div><div id="cmt4c.Author_History"><h3>Author History</h3><p>Hamid Azzedine, PhD (2008-present)<br />Luc Bontoux, MD; Centre Hospitalier Universitaire d'Angers (2008-2015)<br />Eric LeGuern, MD, PhD (2008-present)<br />Mustafa A Salih, MD, Dr Med Sci, FRCPCH, FAAN (2015-present)</p></div><div id="cmt4c.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>15 October 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>6 July 2010 (cd) Revision: edits to Agents/Circumstances to Avoid</div></li><li class="half_rhythm"><div>31 March 2008 (me) Review posted live</div></li><li class="half_rhythm"><div>10 February 2006 (ha) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1340</span><span class="label">PMID: <a href="/pubmed/20301514" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301514</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cmt4/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cmt4h/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1340&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1340/?report=reader">PubReader</a></li><li><a href="/books/NBK1340/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1340" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1340" style="display:none" title="Cite this Page"><div class="bk_tt">Azzedine H, LeGuern E, Salih MA. Charcot-Marie-Tooth Neuropathy Type 4C. 2008 Mar 31 [Updated 2015 Oct 15]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1340/pdf/Bookshelf_NBK1340.pdf">PDF version of this page</a> (268K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#cmt4c.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#cmt4c.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#cmt4c.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#cmt4c.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#cmt4c.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#cmt4c.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#cmt4c.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#cmt4c.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#cmt4c.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#cmt4c.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#cmt4c.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=79628[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SH3TC2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1340+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1485084" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1485084" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1485084" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1485084" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301641" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Charcot-Marie-Tooth Neuropathy Type 4</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Charcot-Marie-Tooth Neuropathy Type 4<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bird TD. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23926620" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Charcot-Marie-Tooth Neuropathy Type 4H</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Charcot-Marie-Tooth Neuropathy Type 4H<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Delague V. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301366" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Charcot-Marie-Tooth Neuropathy Type 2E/1F</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Charcot-Marie-Tooth Neuropathy Type 2E/1F<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">De Jonghe P, Jordanova AK. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301384" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Charcot-Marie-Tooth Neuropathy Type 1</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Charcot-Marie-Tooth Neuropathy Type 1<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bird TD. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20614582" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">DNM2</i>-Related Intermediate Charcot-Marie-Tooth Neuropathy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">DNM2</i>-Related Intermediate Charcot-Marie-Tooth Neuropathy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Züchner S, Tao F. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301514" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301514" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04292b39a66ee2ba9a17a9">Charcot-Marie-Tooth Neuropathy Type 4C - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Charcot-Marie-Tooth Neuropathy Type 4C - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T22:29:47-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8A6C7CE041B6F10000000005EF0221&amp;ncbi_session=CE8A6C7CE04292A1_1519SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1340%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1340&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1340/&amp;ncbi_pagename=Charcot-Marie-Tooth Neuropathy Type 4C - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8A6C7CE04292A1_1519SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>